IMMUNOGENE ZUSAMMENSETZUNGEN

European patent · EP3310381 · Deleted

Register entry

Publication number
EP3310381
Application number
EP16732999
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jun 15, 2016
Published
Apr 25, 2018
Granted
Jun 7, 2023
Deleted
Jan 25, 2024
Reason
Annual fee unpaid
IPC classes
A61K 39/112 (2006.01)
A61K 39/00 (2006.01)
A61P 31/04 (2006.01)
A61P 37/02 (2006.01)
Priority
EP 15020097 16.06.2015
PCT application
PCT/EP2016/063776 15.06.2016
PCT publication
WO2016/202872 22.12.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  2. Apr 17, 2024

    Change

    Published in Swissreg on 17.04.2024

  3. Jan 25, 2024

    Deleted, fee unpaid

    Published in Swissreg on 25.01.2024

  4. Jun 7, 2023

    Granted

    Published in Swissreg on 07.06.2023

Parties

Holder

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Inventor

GERKE, Christiane

53100 Siena, IT

SAUL, Allan James

53100 Siena, IT

MARTIN, Laura Bartle

53100 Siena, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.